Keval Yerigeri

Case Western Reserve University, United States of America

Title: Cardiac Angiosarcomas: Pathophysiology, Diagnosis & Management

Abstract

Cardiac angiosarcomas are a rare, aggressive endothelial cell tumor typically arising from the right atrial wall. They may aggressively invade the surrounding myocardium, resulting in right heart failure, wall rupture, and cardiac tamponade. First-line diagnosis is echocardiography for fast evaluation of tumor extent and complications. Further diagnostic modalities include cardiac MRI, CT and PET/CT scanning. Tumors often require size reduction by chemo (paclitaxel) and radiation prior to surgical resection. Due to its rarity, there is no standardized approach for cardiac sarcomas. This presentation will compare recent findings in the literature on diagnostic modalities, chemotherapy regimens, and surgical approaches.

Biography

Keval Yerigeri is a current Internal Medicine-Pediatrics categorical resident at Case Western Reserve University in Cleveland, OH, USA. He received his M.D. degree from Northeast Ohio Medical University in 2022. Keval has an interest in oncology and epidemiology and completed a research internship as an IRTA trainee at the National Institutes of Health. His current focus is cardiac complications of hematologic and oncologic processes, including hemochromatosis, myxoma, and angiosarcomas. Keval aspires to pursue a fellowship in hematology-oncology and continue prior work on CAR T-based immunotherapies.

4th International Conference on Cardiology

Keval Yerigeri

Title: Cardiac Angiosarcomas: Pathophysiology, Diagnosis & Management

Abstract

Biography

Organization Location

Mail us at

Our Social Presence

Call us at